Publicacións (10) Publicacións de Antonio Dopico López

2024

  1. Preclinical validation of human recombinant glutamate-oxaloacetate transaminase for the treatment of acute ischemic stroke

    iScience, Vol. 27, Núm. 11

2022

  1. Associations between RNA-Binding Motif Protein 3, Fibroblast Growth Factor 21, and Clinical Outcome in Patients with Stroke

    Journal of Clinical Medicine, Vol. 11, Núm. 4

  2. New Perspectives for Developing Therapeutic Bioconjugates of Metabolite-Depleting Enzymes: Lessons Learned Combating Glutamate Excitotoxicity

    Biomacromolecules

2021

  1. Characterization of a temporal profile of biomarkers as an index for ischemic stroke onset definition

    Journal of Clinical Medicine, Vol. 10, Núm. 14

  2. Inhibition of endogenous blood glutamate oxaloacetate transaminase enhances the ischemic damage

    Translational Research, Vol. 230, pp. 68-81

2020

  1. Cold stress protein RBM3 responds to hypothermia and is associated with good stroke outcome

    Brain Communications, Vol. 2, Núm. 2

  2. Sustained blood glutamate scavenging enhances protection in ischemic stroke

    Communications Biology, Vol. 3, Núm. 1

2019

  1. Blood glutamate EAAT2-cell grabbing therapy in cerebral ischemia

    EBioMedicine, Vol. 39, pp. 118-131

2017

  1. Heads and tails of natriuretic peptides: Neuroprotective role of brain natriuretic peptide

    Journal of the American Heart Association, Vol. 6, Núm. 12

  2. Inclusion criteria update for the rat intraluminal ischaemic model for preclinical studies

    DMM Disease Models and Mechanisms, Vol. 10, Núm. 12, pp. 1433-1438